Clinical trials

A drop off in the number of commercially led trials has had an opportunity cost for UK taxpayers of an estimated £360 million over the past five years, says government commissioned review

The EU came up short in running any pan-European clinical trials to advance the development of COVID-19 vaccines and therapies. It is now trying to fix the problem and be better prepared for future health emergencies

Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.